Expression of the water channel protein aquaporin-9 in malignant brain tumors

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 2, 2007, Pages 193-198

  Warth, Arne ^a   Mittelbronn, Michel ^b   Hülper, Petra ^c   Erdlenbruch, Bernhard ^c   Wolburg, Hartwig ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Aquaporin 9; Blood brain barrier; Brain edema; Glioblastoma; RG2 glioma

Indexed keywords

AQUAPORIN 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CELL SURFACE; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 34249694894     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000213110.05108.e9     Document Type: Article

References (40)

1. Nagelhus EA, Mathiisen TM, Ottersen OP. Aquaporin in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience. 2004;129:905-913.
2. Hibino H, Fujita A, Iwai K, et al. Differential assembly of inwardly rectifying K+ channel subunits, Kir4.1 and Kir5.1, in brain astrocytes. J Biol Chem. 2004;279:44065-44073.
3. Badaut J, Petit JM, Brunet JF, et al. Distribution of aquaporin-9 in the adult rat brain: preferential expression in catecholaminergic neurons and in glial cells. Neuroscience. 2004;128:27-38.
4. Badaut J, Regli L. Distribution and possible roles of aquaporin-9 in the brain. Neuroscience. 2004;129:971-981.
5. Unterberg AW, Stover J, Kress B, et al. Edema and brain trauma. Neuroscience. 2004;129:1021-1029.
6. Saadoun S, Papadopoulos MC, Davies DC, et al. Aquaporin-4 expression is increased in oedematous human brain tumors. J Neurol Neurosurg Psychiatry. 2002;72:262-265.
7. Warth A, Kröger S, Wolburg H. Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol. 2004;107:311-318.
8. + channel protein Kir4.1 differs in low- and high-grade human brain tumors. Acta Neuropathol. 2005;109:418-426.
9. Newman E, Reichenbach A. The Müller cell: a functional element of the retina. Trends Neurosci. 1996;19:307-312.
10. Tsukaguchi H, Shayakul C, Berger UV, et al. Molecular characterization of a broad selectivity neutral solute channel. J Biol Chem. 1998;273:24737-24743.
11. Tsukaguchi H, Weremowicz S, Morton CC, et al. Functional and molecular characterization of the human neutral solute channel aquaporin-9. Am J Physiol. 1999;277:F685-F696.
12. Badaut J, Hirt L, Granziera C, et al. Astrocyte-specific expression of aquaporin-9 in mouse brain is increased after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001;21:477-482.
13. Arima H, Yamamoto N, Sobues K, et al. Hyperosmolar mannitol stimulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes. J Biol Chem. 2003;278:44525-44534.
14. Bertrand N, Ishii H, Spatz M. Regional and temporal glycerol changes induced by forebrain ischemia in gerbils. Neurosci Lett. 1992;1-2:81-84.
15. Frykholm P, Hillered L, Langstrom B, et al. Increase of interstitial glycerol reflects the degree of ischemic brain damage: a PET and microdialysis study in a middle cerebral artery occlusion-reperfusion primate model. J Neurol Neurosurg Psychiatry. 2001;71:455-461.
16. Kuo JR, Lin CL, Chio CC, et al. Effects of hypertonic (3%) saline in rats with circulatory shock and cerebral ischemia after heatstroke. Intensive Care Med. 2003;29:1567-1573.
17. Roslin M, Henriksson R, Bergstrom P, et al. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol. 2003;2:151-160.
18. Aas AT, Brun A, Blennow C, et al. The RG2 rat glioma model. J Neurooncol. 1995;3:175-183.
19. Erdlenbruch B, Jendrossek V, Marx M, et al. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo. Anticancer Res. 1998;18:2551-2557.
20. Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press; 2000:9-52.
21. Nag S. Immunohistochemical detection of endothelial proteins. Methods Mol Med. 2003;89:489-501.
22. Wolburg H. Orthogonal arrays of intramembranous particles: a review with special references to astrocytes. J Brain Res. 1995;36:239-258.
23. Behrens PF, Langemann H, Strohschein R et al. Extracellular glutamate and other metabolites in and around rat RG2 glioma: an intracerebral microdialysis study. J Neurooncol. 2000;1:11-22.
24. Mackie K, DePasquale M, Cserr HF. Increased permeability of a glial blood-brain barrier during acute hyperosmotic stress. Am J Physiol. 1986;251:1186-1192.
25. Staub F, Mackert B, Kempinski O, et al. Swelling and death of neuronal cells by lactic acid. J Neurol Sci. 1993;1:79-84.
26. Staub F, Winkler A, Haberstok J, et al. Swelling, intracellular acidosis, and damage of glial cells. Acta Neurochir Suppl. 1996;66:56-62.
27. Magistretti PJ, Pellerin L, Rothman DL, et al. Energy on demand. Science. 1999;283:496-497.
28. Schurr A. Lactate, glucose and energy metabolism in the ischemic brain. Int J Mol Med. 2002;2:131-136.
29. Battison C, Horns BA, Andrews PJD, et al. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7,5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33:196-202.
30. Bereczki D, Liu M, do Prado GF, et al. A systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke. 2000;31:2719-2722.
31. Ricci S, Celani MG, Cantisani AT, et al. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev. 2006; CD000419. DOI: 10.1002/14651858.CD000419.pub2.
32. Zuliani G, Cherubini A, Atti AR, et al. Prescription of anti-oedema agents and short-term mortality in older patients with acute ischaemic stroke. Drugs Aging. 2004;21:273-278.
33. Otsubo K, Katayama Y, Terashi A. Protective effects of glycerol and mannitol on delayed neuronal death in the gerbil hippocampus. Nippon Ika Daigaku Zasshi. 1993;60:231-240.
34. Karibe H, Zarow GJ, Weinstein PR. Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion. J Neurosurg. 1995;83:93-98.
35. Kobayashi H, Die H, Kodera T, et al. Effect of mannitol on focal cerebral ischemia evaluated by magnetic resonance imaging. Acta Neurochir Suppl. 1994;60:228-230.
36. Luvisotto TL, Auer RN, Sutherland GR. The effect of mannitol on experimental cerebral ischemia, revisited. Neurosurgery. 1996;38:131-138.
37. Paczinski RP, He YY, Diringer MN, et al. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke. 1997;28:1437-1443.
38. James HE, Langfitt TW, Kumar VS, et al. Treatment of intracranial hypertension: analysis of 105 consecutive, continous recordings of intracranial pressure. Acta Neurochir (Wien). 1977;36:189-200.
39. Berger C, Sakowitz OW, Kiening KL, et al. Neurochemical monitoring of glycerol therapy in patients with ischemic brain edema. Stroke. 2005;36:e4-e6.
40. Kaufmann AM, Cardoso E. Aggravation of vasogenic cerebral edema by multiple dose mannitol. J Neurosurg. 1992;77:584-589.